PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

Eppendorf Introduces the New BioFlo® 120 Bioprocess Control Station

Leading life science company Eppendorf introduces the BioFlo 120, their latest bench scale fermentor/bioreactor system for research and development. This flexible instrument is capable of microbial fermentation as well as mammalian cell culture applications with a single platform. It features an extensive range of glass and BioBLU® Single-Use Vessel options (250 mL – 40 L). Universal connections for digital Mettler Toledo® ISM and analog sensors make it easy to monitor a variety of critical process parameters.
“We know that in research and development time is critical. Our priority was to develop a bioprocess system that is straightforward to set up and easy to use. By reducing the time required in learning to use new equipment, we free up scientists to spend more time on what is important, their research,” states Kevin Voll, product manager Eppendorf bioprocess.
The embedded software offers real-time local process control through an integrated touchscreen. The newly developed Auto Culture modes for push button control of microbial and cell culture applications drastically reduce the learning curve associated with new equipment. For additional process control capabilities and secure database management the BioFlo 120 can also be connected to Eppendorf SCADA platforms DASware® and BioCommand®.
“A very user-friendly system, which is self-explanatory” summarized Hamid Tehrani at RWTH Aachen University, after using the new control station for a few weeks.
Ease of use and flexibility ensure the new bioreactor/fermentor serves the needs of scientists today and in the years to come – be it in academic, governmental, or industrial research settings.
The new BioFlo 120 bioprocess control station will be presented at the BioProcess International Europe in Amsterdam, the BioProcess International West in San Francisco, the BioPharm Asia in Singapore, and other industry events. Interested visitors can learn about the new product at the Eppendorf booths or at www.eppendorf.com/BioFlo120.
 

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026